nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—PDE5A—coronary artery disease	0.507	1	CbGaD
Tadalafil—CYP3A4—Ticagrelor—coronary artery disease	0.0306	0.146	CbGbCtD
Tadalafil—CYP3A4—Fenofibrate—coronary artery disease	0.0273	0.131	CbGbCtD
Tadalafil—CYP3A4—Gemfibrozil—coronary artery disease	0.0218	0.104	CbGbCtD
Tadalafil—CYP3A4—Clopidogrel—coronary artery disease	0.0189	0.0905	CbGbCtD
Tadalafil—CYP3A4—Eplerenone—coronary artery disease	0.0176	0.0841	CbGbCtD
Tadalafil—CYP3A4—Enalapril—coronary artery disease	0.0157	0.075	CbGbCtD
Tadalafil—CYP3A4—Rosuvastatin—coronary artery disease	0.0122	0.0583	CbGbCtD
Tadalafil—CYP3A4—Ezetimibe—coronary artery disease	0.0122	0.0583	CbGbCtD
Tadalafil—CYP3A4—Simvastatin—coronary artery disease	0.0113	0.0542	CbGbCtD
Tadalafil—CYP3A4—Lovastatin—coronary artery disease	0.0111	0.053	CbGbCtD
Tadalafil—CYP3A4—Pravastatin—coronary artery disease	0.0111	0.053	CbGbCtD
Tadalafil—CYP3A4—Atorvastatin—coronary artery disease	0.0101	0.0483	CbGbCtD
Tadalafil—CYP3A4—Losartan—coronary artery disease	0.00925	0.0442	CbGbCtD
Tadalafil—PDE5A—pulmonary artery—coronary artery disease	0.00894	0.41	CbGeAlD
Tadalafil—PDE5A—artery—coronary artery disease	0.00331	0.152	CbGeAlD
Tadalafil—PDE11A—heart—coronary artery disease	0.00321	0.147	CbGeAlD
Tadalafil—PDE5A—endothelium—coronary artery disease	0.0028	0.128	CbGeAlD
Tadalafil—PDE5A—heart—coronary artery disease	0.00122	0.0559	CbGeAlD
Tadalafil—PDE5A—cardiovascular system—coronary artery disease	0.00115	0.0528	CbGeAlD
Tadalafil—PDE5A—blood—coronary artery disease	0.000911	0.0417	CbGeAlD
Tadalafil—CYP3A4—blood—coronary artery disease	0.000284	0.013	CbGeAlD
Tadalafil—Hypersensitivity—Niacin—coronary artery disease	6.09e-05	0.000346	CcSEcCtD
Tadalafil—Discomfort—Ramipril—coronary artery disease	6.08e-05	0.000345	CcSEcCtD
Tadalafil—Asthenia—Olmesartan—coronary artery disease	6.07e-05	0.000345	CcSEcCtD
Tadalafil—Headache—Clopidogrel—coronary artery disease	6.07e-05	0.000345	CcSEcCtD
Tadalafil—Rash—Lovastatin—coronary artery disease	6.07e-05	0.000345	CcSEcCtD
Tadalafil—Dermatitis—Lovastatin—coronary artery disease	6.07e-05	0.000344	CcSEcCtD
Tadalafil—Dyspepsia—Losartan—coronary artery disease	6.06e-05	0.000344	CcSEcCtD
Tadalafil—Headache—Lovastatin—coronary artery disease	6.03e-05	0.000343	CcSEcCtD
Tadalafil—Pruritus—Valsartan—coronary artery disease	6.02e-05	0.000342	CcSEcCtD
Tadalafil—Dry mouth—Ramipril—coronary artery disease	6.02e-05	0.000342	CcSEcCtD
Tadalafil—Chest pain—Timolol—coronary artery disease	6.02e-05	0.000342	CcSEcCtD
Tadalafil—Myalgia—Timolol—coronary artery disease	6.02e-05	0.000342	CcSEcCtD
Tadalafil—Arthralgia—Timolol—coronary artery disease	6.02e-05	0.000342	CcSEcCtD
Tadalafil—Vomiting—Ezetimibe—coronary artery disease	6.01e-05	0.000341	CcSEcCtD
Tadalafil—Hypersensitivity—Pravastatin—coronary artery disease	6e-05	0.000341	CcSEcCtD
Tadalafil—Gastrointestinal pain—Perindopril—coronary artery disease	6e-05	0.000341	CcSEcCtD
Tadalafil—Angioedema—Lisinopril—coronary artery disease	5.99e-05	0.00034	CcSEcCtD
Tadalafil—Pruritus—Olmesartan—coronary artery disease	5.99e-05	0.00034	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.97e-05	0.000339	CcSEcCtD
Tadalafil—Abdominal pain—Captopril—coronary artery disease	5.97e-05	0.000339	CcSEcCtD
Tadalafil—Dizziness—Simvastatin—coronary artery disease	5.96e-05	0.000338	CcSEcCtD
Tadalafil—Rash—Ezetimibe—coronary artery disease	5.96e-05	0.000338	CcSEcCtD
Tadalafil—Dermatitis—Ezetimibe—coronary artery disease	5.95e-05	0.000338	CcSEcCtD
Tadalafil—Discomfort—Timolol—coronary artery disease	5.94e-05	0.000338	CcSEcCtD
Tadalafil—Asthenia—Niacin—coronary artery disease	5.93e-05	0.000337	CcSEcCtD
Tadalafil—Fatigue—Losartan—coronary artery disease	5.93e-05	0.000337	CcSEcCtD
Tadalafil—Headache—Ezetimibe—coronary artery disease	5.92e-05	0.000336	CcSEcCtD
Tadalafil—Oedema—Ramipril—coronary artery disease	5.9e-05	0.000335	CcSEcCtD
Tadalafil—Vertigo—Lisinopril—coronary artery disease	5.89e-05	0.000334	CcSEcCtD
Tadalafil—Dry mouth—Timolol—coronary artery disease	5.88e-05	0.000334	CcSEcCtD
Tadalafil—Constipation—Losartan—coronary artery disease	5.88e-05	0.000334	CcSEcCtD
Tadalafil—Pain—Losartan—coronary artery disease	5.88e-05	0.000334	CcSEcCtD
Tadalafil—Syncope—Lisinopril—coronary artery disease	5.88e-05	0.000334	CcSEcCtD
Tadalafil—Vomiting—Eplerenone—coronary artery disease	5.88e-05	0.000334	CcSEcCtD
Tadalafil—Nausea—Fenofibrate—coronary artery disease	5.86e-05	0.000333	CcSEcCtD
Tadalafil—Pruritus—Niacin—coronary artery disease	5.85e-05	0.000332	CcSEcCtD
Tadalafil—Asthenia—Pravastatin—coronary artery disease	5.84e-05	0.000332	CcSEcCtD
Tadalafil—Gastrointestinal pain—Furosemide—coronary artery disease	5.83e-05	0.000331	CcSEcCtD
Tadalafil—Rash—Eplerenone—coronary artery disease	5.83e-05	0.000331	CcSEcCtD
Tadalafil—Urticaria—Perindopril—coronary artery disease	5.83e-05	0.000331	CcSEcCtD
Tadalafil—Hypersensitivity—Trandolapril—coronary artery disease	5.83e-05	0.000331	CcSEcCtD
Tadalafil—Dermatitis—Eplerenone—coronary artery disease	5.82e-05	0.000331	CcSEcCtD
Tadalafil—Diarrhoea—Valsartan—coronary artery disease	5.82e-05	0.00033	CcSEcCtD
Tadalafil—Shock—Ramipril—coronary artery disease	5.8e-05	0.00033	CcSEcCtD
Tadalafil—Hypersensitivity—Enalapril—coronary artery disease	5.8e-05	0.00033	CcSEcCtD
Tadalafil—Abdominal pain—Perindopril—coronary artery disease	5.8e-05	0.000329	CcSEcCtD
Tadalafil—Palpitations—Lisinopril—coronary artery disease	5.79e-05	0.000329	CcSEcCtD
Tadalafil—Diarrhoea—Olmesartan—coronary artery disease	5.79e-05	0.000329	CcSEcCtD
Tadalafil—Headache—Eplerenone—coronary artery disease	5.79e-05	0.000329	CcSEcCtD
Tadalafil—Nervous system disorder—Ramipril—coronary artery disease	5.79e-05	0.000328	CcSEcCtD
Tadalafil—Oedema—Timolol—coronary artery disease	5.77e-05	0.000327	CcSEcCtD
Tadalafil—Pruritus—Pravastatin—coronary artery disease	5.76e-05	0.000327	CcSEcCtD
Tadalafil—Loss of consciousness—Lisinopril—coronary artery disease	5.76e-05	0.000327	CcSEcCtD
Tadalafil—Nausea—Clopidogrel—coronary artery disease	5.76e-05	0.000327	CcSEcCtD
Tadalafil—Tachycardia—Ramipril—coronary artery disease	5.76e-05	0.000327	CcSEcCtD
Tadalafil—Skin disorder—Ramipril—coronary artery disease	5.73e-05	0.000325	CcSEcCtD
Tadalafil—Infection—Timolol—coronary artery disease	5.73e-05	0.000325	CcSEcCtD
Tadalafil—Vomiting—Simvastatin—coronary artery disease	5.73e-05	0.000325	CcSEcCtD
Tadalafil—Hypersensitivity—Telmisartan—coronary artery disease	5.72e-05	0.000325	CcSEcCtD
Tadalafil—Cough—Lisinopril—coronary artery disease	5.72e-05	0.000325	CcSEcCtD
Tadalafil—Nausea—Lovastatin—coronary artery disease	5.72e-05	0.000325	CcSEcCtD
Tadalafil—Hyperhidrosis—Ramipril—coronary artery disease	5.7e-05	0.000324	CcSEcCtD
Tadalafil—Rash—Simvastatin—coronary artery disease	5.68e-05	0.000322	CcSEcCtD
Tadalafil—Dermatitis—Simvastatin—coronary artery disease	5.67e-05	0.000322	CcSEcCtD
Tadalafil—Asthenia—Trandolapril—coronary artery disease	5.67e-05	0.000322	CcSEcCtD
Tadalafil—Shock—Timolol—coronary artery disease	5.67e-05	0.000322	CcSEcCtD
Tadalafil—Urticaria—Furosemide—coronary artery disease	5.66e-05	0.000322	CcSEcCtD
Tadalafil—Diarrhoea—Niacin—coronary artery disease	5.66e-05	0.000321	CcSEcCtD
Tadalafil—Nervous system disorder—Timolol—coronary artery disease	5.66e-05	0.000321	CcSEcCtD
Tadalafil—Asthenia—Enalapril—coronary artery disease	5.65e-05	0.000321	CcSEcCtD
Tadalafil—Headache—Simvastatin—coronary artery disease	5.64e-05	0.00032	CcSEcCtD
Tadalafil—Abdominal pain—Furosemide—coronary artery disease	5.64e-05	0.00032	CcSEcCtD
Tadalafil—Gastrointestinal pain—Losartan—coronary artery disease	5.63e-05	0.000319	CcSEcCtD
Tadalafil—Dizziness—Valsartan—coronary artery disease	5.63e-05	0.000319	CcSEcCtD
Tadalafil—Nausea—Ezetimibe—coronary artery disease	5.61e-05	0.000319	CcSEcCtD
Tadalafil—Skin disorder—Timolol—coronary artery disease	5.6e-05	0.000318	CcSEcCtD
Tadalafil—Dizziness—Olmesartan—coronary artery disease	5.6e-05	0.000318	CcSEcCtD
Tadalafil—Pruritus—Trandolapril—coronary artery disease	5.6e-05	0.000318	CcSEcCtD
Tadalafil—Chest pain—Lisinopril—coronary artery disease	5.58e-05	0.000317	CcSEcCtD
Tadalafil—Myalgia—Lisinopril—coronary artery disease	5.58e-05	0.000317	CcSEcCtD
Tadalafil—Arthralgia—Lisinopril—coronary artery disease	5.58e-05	0.000317	CcSEcCtD
Tadalafil—Hyperhidrosis—Timolol—coronary artery disease	5.58e-05	0.000317	CcSEcCtD
Tadalafil—Asthenia—Telmisartan—coronary artery disease	5.57e-05	0.000317	CcSEcCtD
Tadalafil—Pruritus—Enalapril—coronary artery disease	5.57e-05	0.000316	CcSEcCtD
Tadalafil—Diarrhoea—Pravastatin—coronary artery disease	5.57e-05	0.000316	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.54e-05	0.000315	CcSEcCtD
Tadalafil—Discomfort—Lisinopril—coronary artery disease	5.51e-05	0.000313	CcSEcCtD
Tadalafil—Hypotension—Ramipril—coronary artery disease	5.51e-05	0.000313	CcSEcCtD
Tadalafil—Pruritus—Telmisartan—coronary artery disease	5.5e-05	0.000312	CcSEcCtD
Tadalafil—Nausea—Eplerenone—coronary artery disease	5.49e-05	0.000312	CcSEcCtD
Tadalafil—Dizziness—Niacin—coronary artery disease	5.47e-05	0.000311	CcSEcCtD
Tadalafil—Urticaria—Losartan—coronary artery disease	5.47e-05	0.00031	CcSEcCtD
Tadalafil—Dry mouth—Lisinopril—coronary artery disease	5.46e-05	0.00031	CcSEcCtD
Tadalafil—Abdominal pain—Losartan—coronary artery disease	5.44e-05	0.000309	CcSEcCtD
Tadalafil—Asthenia—Captopril—coronary artery disease	5.42e-05	0.000308	CcSEcCtD
Tadalafil—Diarrhoea—Trandolapril—coronary artery disease	5.41e-05	0.000307	CcSEcCtD
Tadalafil—Vomiting—Valsartan—coronary artery disease	5.41e-05	0.000307	CcSEcCtD
Tadalafil—Diarrhoea—Enalapril—coronary artery disease	5.39e-05	0.000306	CcSEcCtD
Tadalafil—Hypotension—Timolol—coronary artery disease	5.39e-05	0.000306	CcSEcCtD
Tadalafil—Dizziness—Pravastatin—coronary artery disease	5.39e-05	0.000306	CcSEcCtD
Tadalafil—Vomiting—Olmesartan—coronary artery disease	5.38e-05	0.000306	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.37e-05	0.000305	CcSEcCtD
Tadalafil—Rash—Valsartan—coronary artery disease	5.36e-05	0.000305	CcSEcCtD
Tadalafil—Dermatitis—Valsartan—coronary artery disease	5.36e-05	0.000304	CcSEcCtD
Tadalafil—Nausea—Simvastatin—coronary artery disease	5.35e-05	0.000304	CcSEcCtD
Tadalafil—Oedema—Lisinopril—coronary artery disease	5.35e-05	0.000304	CcSEcCtD
Tadalafil—Pruritus—Captopril—coronary artery disease	5.34e-05	0.000303	CcSEcCtD
Tadalafil—Rash—Olmesartan—coronary artery disease	5.34e-05	0.000303	CcSEcCtD
Tadalafil—Insomnia—Ramipril—coronary artery disease	5.34e-05	0.000303	CcSEcCtD
Tadalafil—Dermatitis—Olmesartan—coronary artery disease	5.33e-05	0.000303	CcSEcCtD
Tadalafil—Headache—Valsartan—coronary artery disease	5.33e-05	0.000303	CcSEcCtD
Tadalafil—Diarrhoea—Telmisartan—coronary artery disease	5.32e-05	0.000302	CcSEcCtD
Tadalafil—Infection—Lisinopril—coronary artery disease	5.32e-05	0.000302	CcSEcCtD
Tadalafil—Headache—Olmesartan—coronary artery disease	5.3e-05	0.000301	CcSEcCtD
Tadalafil—Paraesthesia—Ramipril—coronary artery disease	5.3e-05	0.000301	CcSEcCtD
Tadalafil—Shock—Lisinopril—coronary artery disease	5.26e-05	0.000299	CcSEcCtD
Tadalafil—Asthenia—Perindopril—coronary artery disease	5.26e-05	0.000299	CcSEcCtD
Tadalafil—Dyspnoea—Ramipril—coronary artery disease	5.26e-05	0.000299	CcSEcCtD
Tadalafil—Vomiting—Niacin—coronary artery disease	5.26e-05	0.000299	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Timolol—coronary artery disease	5.25e-05	0.000298	CcSEcCtD
Tadalafil—Hypersensitivity—Furosemide—coronary artery disease	5.25e-05	0.000298	CcSEcCtD
Tadalafil—Somnolence—Ramipril—coronary artery disease	5.24e-05	0.000298	CcSEcCtD
Tadalafil—Dizziness—Trandolapril—coronary artery disease	5.23e-05	0.000297	CcSEcCtD
Tadalafil—Tachycardia—Lisinopril—coronary artery disease	5.22e-05	0.000296	CcSEcCtD
Tadalafil—Insomnia—Timolol—coronary artery disease	5.22e-05	0.000296	CcSEcCtD
Tadalafil—Rash—Niacin—coronary artery disease	5.22e-05	0.000296	CcSEcCtD
Tadalafil—Dermatitis—Niacin—coronary artery disease	5.21e-05	0.000296	CcSEcCtD
Tadalafil—Dizziness—Enalapril—coronary artery disease	5.21e-05	0.000296	CcSEcCtD
Tadalafil—Skin disorder—Lisinopril—coronary artery disease	5.2e-05	0.000295	CcSEcCtD
Tadalafil—Dyspepsia—Ramipril—coronary artery disease	5.19e-05	0.000295	CcSEcCtD
Tadalafil—Pruritus—Perindopril—coronary artery disease	5.19e-05	0.000295	CcSEcCtD
Tadalafil—Headache—Niacin—coronary artery disease	5.18e-05	0.000294	CcSEcCtD
Tadalafil—Paraesthesia—Timolol—coronary artery disease	5.18e-05	0.000294	CcSEcCtD
Tadalafil—Vomiting—Pravastatin—coronary artery disease	5.18e-05	0.000294	CcSEcCtD
Tadalafil—Hyperhidrosis—Lisinopril—coronary artery disease	5.17e-05	0.000294	CcSEcCtD
Tadalafil—Diarrhoea—Captopril—coronary artery disease	5.17e-05	0.000293	CcSEcCtD
Tadalafil—Dyspnoea—Timolol—coronary artery disease	5.14e-05	0.000292	CcSEcCtD
Tadalafil—Dizziness—Telmisartan—coronary artery disease	5.14e-05	0.000292	CcSEcCtD
Tadalafil—Rash—Pravastatin—coronary artery disease	5.13e-05	0.000292	CcSEcCtD
Tadalafil—Dermatitis—Pravastatin—coronary artery disease	5.13e-05	0.000291	CcSEcCtD
Tadalafil—Somnolence—Timolol—coronary artery disease	5.13e-05	0.000291	CcSEcCtD
Tadalafil—Asthenia—Furosemide—coronary artery disease	5.12e-05	0.00029	CcSEcCtD
Tadalafil—Headache—Pravastatin—coronary artery disease	5.1e-05	0.00029	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Ramipril—coronary artery disease	5.09e-05	0.000289	CcSEcCtD
Tadalafil—Fatigue—Ramipril—coronary artery disease	5.09e-05	0.000289	CcSEcCtD
Tadalafil—Dyspepsia—Timolol—coronary artery disease	5.08e-05	0.000288	CcSEcCtD
Tadalafil—Hypersensitivity—Losartan—coronary artery disease	5.07e-05	0.000288	CcSEcCtD
Tadalafil—Nausea—Valsartan—coronary artery disease	5.05e-05	0.000287	CcSEcCtD
Tadalafil—Pruritus—Furosemide—coronary artery disease	5.04e-05	0.000286	CcSEcCtD
Tadalafil—Constipation—Ramipril—coronary artery disease	5.04e-05	0.000286	CcSEcCtD
Tadalafil—Nausea—Olmesartan—coronary artery disease	5.03e-05	0.000286	CcSEcCtD
Tadalafil—Vomiting—Trandolapril—coronary artery disease	5.03e-05	0.000286	CcSEcCtD
Tadalafil—Diarrhoea—Perindopril—coronary artery disease	5.02e-05	0.000285	CcSEcCtD
Tadalafil—Vomiting—Enalapril—coronary artery disease	5.01e-05	0.000284	CcSEcCtD
Tadalafil—Hypotension—Lisinopril—coronary artery disease	5e-05	0.000284	CcSEcCtD
Tadalafil—Dizziness—Captopril—coronary artery disease	5e-05	0.000284	CcSEcCtD
Tadalafil—Rash—Trandolapril—coronary artery disease	4.99e-05	0.000283	CcSEcCtD
Tadalafil—Dermatitis—Trandolapril—coronary artery disease	4.98e-05	0.000283	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Timolol—coronary artery disease	4.98e-05	0.000283	CcSEcCtD
Tadalafil—Fatigue—Timolol—coronary artery disease	4.97e-05	0.000282	CcSEcCtD
Tadalafil—Rash—Enalapril—coronary artery disease	4.97e-05	0.000282	CcSEcCtD
Tadalafil—Dermatitis—Enalapril—coronary artery disease	4.96e-05	0.000282	CcSEcCtD
Tadalafil—Headache—Trandolapril—coronary artery disease	4.95e-05	0.000281	CcSEcCtD
Tadalafil—Vomiting—Telmisartan—coronary artery disease	4.94e-05	0.00028	CcSEcCtD
Tadalafil—Asthenia—Losartan—coronary artery disease	4.94e-05	0.00028	CcSEcCtD
Tadalafil—Headache—Enalapril—coronary artery disease	4.93e-05	0.00028	CcSEcCtD
Tadalafil—Pain—Timolol—coronary artery disease	4.93e-05	0.00028	CcSEcCtD
Tadalafil—Nausea—Niacin—coronary artery disease	4.91e-05	0.000279	CcSEcCtD
Tadalafil—Rash—Telmisartan—coronary artery disease	4.9e-05	0.000278	CcSEcCtD
Tadalafil—Dermatitis—Telmisartan—coronary artery disease	4.89e-05	0.000278	CcSEcCtD
Tadalafil—Diarrhoea—Furosemide—coronary artery disease	4.88e-05	0.000277	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.87e-05	0.000277	CcSEcCtD
Tadalafil—Pruritus—Losartan—coronary artery disease	4.87e-05	0.000276	CcSEcCtD
Tadalafil—Headache—Telmisartan—coronary artery disease	4.87e-05	0.000276	CcSEcCtD
Tadalafil—Dizziness—Perindopril—coronary artery disease	4.85e-05	0.000275	CcSEcCtD
Tadalafil—Insomnia—Lisinopril—coronary artery disease	4.84e-05	0.000275	CcSEcCtD
Tadalafil—Nausea—Pravastatin—coronary artery disease	4.84e-05	0.000275	CcSEcCtD
Tadalafil—Gastrointestinal pain—Ramipril—coronary artery disease	4.82e-05	0.000274	CcSEcCtD
Tadalafil—Paraesthesia—Lisinopril—coronary artery disease	4.8e-05	0.000273	CcSEcCtD
Tadalafil—Vomiting—Captopril—coronary artery disease	4.8e-05	0.000273	CcSEcCtD
Tadalafil—Dyspnoea—Lisinopril—coronary artery disease	4.77e-05	0.000271	CcSEcCtD
Tadalafil—Rash—Captopril—coronary artery disease	4.76e-05	0.00027	CcSEcCtD
Tadalafil—Dermatitis—Captopril—coronary artery disease	4.76e-05	0.00027	CcSEcCtD
Tadalafil—Somnolence—Lisinopril—coronary artery disease	4.76e-05	0.00027	CcSEcCtD
Tadalafil—Headache—Captopril—coronary artery disease	4.73e-05	0.000269	CcSEcCtD
Tadalafil—Gastrointestinal pain—Timolol—coronary artery disease	4.72e-05	0.000268	CcSEcCtD
Tadalafil—Dizziness—Furosemide—coronary artery disease	4.72e-05	0.000268	CcSEcCtD
Tadalafil—Dyspepsia—Lisinopril—coronary artery disease	4.71e-05	0.000267	CcSEcCtD
Tadalafil—Diarrhoea—Losartan—coronary artery disease	4.71e-05	0.000267	CcSEcCtD
Tadalafil—Nausea—Trandolapril—coronary artery disease	4.7e-05	0.000267	CcSEcCtD
Tadalafil—Urticaria—Ramipril—coronary artery disease	4.69e-05	0.000266	CcSEcCtD
Tadalafil—Nausea—Enalapril—coronary artery disease	4.68e-05	0.000266	CcSEcCtD
Tadalafil—Vomiting—Perindopril—coronary artery disease	4.66e-05	0.000265	CcSEcCtD
Tadalafil—Abdominal pain—Ramipril—coronary artery disease	4.66e-05	0.000265	CcSEcCtD
Tadalafil—Rash—Perindopril—coronary artery disease	4.62e-05	0.000263	CcSEcCtD
Tadalafil—Dermatitis—Perindopril—coronary artery disease	4.62e-05	0.000262	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.62e-05	0.000262	CcSEcCtD
Tadalafil—Nausea—Telmisartan—coronary artery disease	4.61e-05	0.000262	CcSEcCtD
Tadalafil—Fatigue—Lisinopril—coronary artery disease	4.61e-05	0.000262	CcSEcCtD
Tadalafil—Headache—Perindopril—coronary artery disease	4.6e-05	0.000261	CcSEcCtD
Tadalafil—Urticaria—Timolol—coronary artery disease	4.58e-05	0.00026	CcSEcCtD
Tadalafil—Constipation—Lisinopril—coronary artery disease	4.58e-05	0.00026	CcSEcCtD
Tadalafil—Pain—Lisinopril—coronary artery disease	4.58e-05	0.00026	CcSEcCtD
Tadalafil—Abdominal pain—Timolol—coronary artery disease	4.56e-05	0.000259	CcSEcCtD
Tadalafil—Dizziness—Losartan—coronary artery disease	4.55e-05	0.000258	CcSEcCtD
Tadalafil—Vomiting—Furosemide—coronary artery disease	4.53e-05	0.000257	CcSEcCtD
Tadalafil—Rash—Furosemide—coronary artery disease	4.5e-05	0.000255	CcSEcCtD
Tadalafil—Dermatitis—Furosemide—coronary artery disease	4.49e-05	0.000255	CcSEcCtD
Tadalafil—Nausea—Captopril—coronary artery disease	4.49e-05	0.000255	CcSEcCtD
Tadalafil—Headache—Furosemide—coronary artery disease	4.47e-05	0.000254	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	4.41e-05	0.000514	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CRK—coronary artery disease	4.39e-05	0.000511	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Lisinopril—coronary artery disease	4.37e-05	0.000248	CcSEcCtD
Tadalafil—Vomiting—Losartan—coronary artery disease	4.37e-05	0.000248	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—NOS3—coronary artery disease	4.37e-05	0.000509	CbGpPWpGaD
Tadalafil—Nausea—Perindopril—coronary artery disease	4.36e-05	0.000247	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	4.35e-05	0.000507	CbGpPWpGaD
Tadalafil—Hypersensitivity—Ramipril—coronary artery disease	4.35e-05	0.000247	CcSEcCtD
Tadalafil—Rash—Losartan—coronary artery disease	4.34e-05	0.000246	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—SH2B3—coronary artery disease	4.34e-05	0.000505	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ATP2A2—coronary artery disease	4.34e-05	0.000505	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VWF—coronary artery disease	4.34e-05	0.000505	CbGpPWpGaD
Tadalafil—Dermatitis—Losartan—coronary artery disease	4.33e-05	0.000246	CcSEcCtD
Tadalafil—Headache—Losartan—coronary artery disease	4.31e-05	0.000245	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—APOC3—coronary artery disease	4.31e-05	0.000502	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LDLR—coronary artery disease	4.28e-05	0.000499	CbGpPWpGaD
Tadalafil—Urticaria—Lisinopril—coronary artery disease	4.25e-05	0.000241	CcSEcCtD
Tadalafil—Hypersensitivity—Timolol—coronary artery disease	4.25e-05	0.000241	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—JAK2—coronary artery disease	4.25e-05	0.000494	CbGpPWpGaD
Tadalafil—Nausea—Furosemide—coronary artery disease	4.24e-05	0.00024	CcSEcCtD
Tadalafil—Asthenia—Ramipril—coronary artery disease	4.23e-05	0.00024	CcSEcCtD
Tadalafil—Abdominal pain—Lisinopril—coronary artery disease	4.23e-05	0.00024	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—AGT—coronary artery disease	4.22e-05	0.000491	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PPP2CA—coronary artery disease	4.2e-05	0.000489	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL2—coronary artery disease	4.18e-05	0.000487	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL3—coronary artery disease	4.18e-05	0.000487	CbGpPWpGaD
Tadalafil—Pruritus—Ramipril—coronary artery disease	4.17e-05	0.000237	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	4.15e-05	0.000484	CbGpPWpGaD
Tadalafil—Asthenia—Timolol—coronary artery disease	4.14e-05	0.000235	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—SDC1—coronary artery disease	4.14e-05	0.000482	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—F2R—coronary artery disease	4.14e-05	0.000482	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	4.13e-05	0.000481	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRKCD—coronary artery disease	4.13e-05	0.000481	CbGpPWpGaD
Tadalafil—Nausea—Losartan—coronary artery disease	4.09e-05	0.000232	CcSEcCtD
Tadalafil—Pruritus—Timolol—coronary artery disease	4.08e-05	0.000232	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—FGB—coronary artery disease	4.05e-05	0.000471	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR2A—coronary artery disease	4.04e-05	0.00047	CbGpPWpGaD
Tadalafil—Diarrhoea—Ramipril—coronary artery disease	4.04e-05	0.000229	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—C3—coronary artery disease	4.03e-05	0.00047	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EDNRB—coronary artery disease	4.01e-05	0.000467	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—THBS1—coronary artery disease	3.95e-05	0.00046	CbGpPWpGaD
Tadalafil—Diarrhoea—Timolol—coronary artery disease	3.95e-05	0.000224	CcSEcCtD
Tadalafil—Hypersensitivity—Lisinopril—coronary artery disease	3.94e-05	0.000224	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PSMB5—coronary artery disease	3.91e-05	0.000455	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PSMA6—coronary artery disease	3.91e-05	0.000455	CbGpPWpGaD
Tadalafil—Dizziness—Ramipril—coronary artery disease	3.9e-05	0.000222	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—F2—coronary artery disease	3.9e-05	0.000454	CbGpPWpGaD
Tadalafil—Asthenia—Lisinopril—coronary artery disease	3.84e-05	0.000218	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—AGT—coronary artery disease	3.83e-05	0.000446	CbGpPWpGaD
Tadalafil—Dizziness—Timolol—coronary artery disease	3.81e-05	0.000217	CcSEcCtD
Tadalafil—Pruritus—Lisinopril—coronary artery disease	3.79e-05	0.000215	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—EDNRA—coronary artery disease	3.78e-05	0.000441	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CYBA—coronary artery disease	3.77e-05	0.000439	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADRB1—coronary artery disease	3.77e-05	0.000439	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GCLM—coronary artery disease	3.75e-05	0.000437	CbGpPWpGaD
Tadalafil—Vomiting—Ramipril—coronary artery disease	3.75e-05	0.000213	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—DUSP6—coronary artery disease	3.75e-05	0.000437	CbGpPWpGaD
Tadalafil—Rash—Ramipril—coronary artery disease	3.72e-05	0.000211	CcSEcCtD
Tadalafil—Dermatitis—Ramipril—coronary artery disease	3.72e-05	0.000211	CcSEcCtD
Tadalafil—Headache—Ramipril—coronary artery disease	3.7e-05	0.00021	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PLAT—coronary artery disease	3.69e-05	0.000429	CbGpPWpGaD
Tadalafil—Vomiting—Timolol—coronary artery disease	3.67e-05	0.000208	CcSEcCtD
Tadalafil—Diarrhoea—Lisinopril—coronary artery disease	3.66e-05	0.000208	CcSEcCtD
Tadalafil—Rash—Timolol—coronary artery disease	3.64e-05	0.000206	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	3.64e-05	0.000423	CbGpPWpGaD
Tadalafil—Dermatitis—Timolol—coronary artery disease	3.63e-05	0.000206	CcSEcCtD
Tadalafil—Headache—Timolol—coronary artery disease	3.61e-05	0.000205	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	3.59e-05	0.000418	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BDKRB2—coronary artery disease	3.56e-05	0.000414	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL12—coronary artery disease	3.56e-05	0.000414	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—POMC—coronary artery disease	3.55e-05	0.000414	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—F2—coronary artery disease	3.54e-05	0.000412	CbGpPWpGaD
Tadalafil—Dizziness—Lisinopril—coronary artery disease	3.54e-05	0.000201	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—VEGFA—coronary artery disease	3.53e-05	0.000411	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6ST—coronary artery disease	3.53e-05	0.000411	CbGpPWpGaD
Tadalafil—Nausea—Ramipril—coronary artery disease	3.5e-05	0.000199	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—JUNB—coronary artery disease	3.49e-05	0.000407	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PLCB1—coronary artery disease	3.48e-05	0.000405	CbGpPWpGaD
Tadalafil—Nausea—Timolol—coronary artery disease	3.43e-05	0.000195	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HTR7—coronary artery disease	3.41e-05	0.000397	CbGpPWpGaD
Tadalafil—Vomiting—Lisinopril—coronary artery disease	3.4e-05	0.000193	CcSEcCtD
Tadalafil—Rash—Lisinopril—coronary artery disease	3.37e-05	0.000192	CcSEcCtD
Tadalafil—Dermatitis—Lisinopril—coronary artery disease	3.37e-05	0.000191	CcSEcCtD
Tadalafil—Headache—Lisinopril—coronary artery disease	3.35e-05	0.00019	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	3.3e-05	0.000385	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	3.3e-05	0.000384	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	3.26e-05	0.00038	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	3.26e-05	0.00038	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ITGAV—coronary artery disease	3.25e-05	0.000378	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TGFB1—coronary artery disease	3.24e-05	0.000377	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KNG1—coronary artery disease	3.24e-05	0.000377	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	3.23e-05	0.000376	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—POMC—coronary artery disease	3.23e-05	0.000376	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CREB1—coronary artery disease	3.23e-05	0.000376	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGTR1—coronary artery disease	3.22e-05	0.000375	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MAPK1—coronary artery disease	3.18e-05	0.00037	CbGpPWpGaD
Tadalafil—Nausea—Lisinopril—coronary artery disease	3.18e-05	0.00018	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CCL2—coronary artery disease	3.16e-05	0.000368	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—coronary artery disease	3.15e-05	0.000367	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6R—coronary artery disease	3.15e-05	0.000366	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL10—coronary artery disease	3.14e-05	0.000366	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PLG—coronary artery disease	3.13e-05	0.000365	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADRB2—coronary artery disease	3.05e-05	0.000355	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCE—coronary artery disease	3.01e-05	0.000351	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—JAK2—coronary artery disease	3.01e-05	0.000351	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SOCS1—coronary artery disease	3.01e-05	0.00035	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—S100B—coronary artery disease	3e-05	0.000349	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SOCS3—coronary artery disease	2.97e-05	0.000346	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KITLG—coronary artery disease	2.93e-05	0.000342	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFBR2—coronary artery disease	2.93e-05	0.000342	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TGFB1—coronary artery disease	2.89e-05	0.000336	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP3—coronary artery disease	2.87e-05	0.000334	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT5A—coronary artery disease	2.87e-05	0.000334	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MAPK1—coronary artery disease	2.83e-05	0.00033	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOB—coronary artery disease	2.77e-05	0.000323	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CA—coronary artery disease	2.76e-05	0.000321	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—coronary artery disease	2.75e-05	0.00032	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—JAK2—coronary artery disease	2.73e-05	0.000318	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EDN1—coronary artery disease	2.73e-05	0.000318	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL5—coronary artery disease	2.71e-05	0.000315	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	2.68e-05	0.000312	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGF1—coronary artery disease	2.67e-05	0.00031	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CSF2—coronary artery disease	2.67e-05	0.00031	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LPL—coronary artery disease	2.65e-05	0.000308	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MEF2C—coronary artery disease	2.62e-05	0.000305	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RPS6KB1—coronary artery disease	2.62e-05	0.000305	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	2.6e-05	0.000303	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	2.59e-05	0.000301	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ITGB3—coronary artery disease	2.56e-05	0.000298	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	2.54e-05	0.000295	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	2.5e-05	0.000291	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—coronary artery disease	2.49e-05	0.000291	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PPP2CA—coronary artery disease	2.48e-05	0.000289	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	2.47e-05	0.000288	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CA—coronary artery disease	2.46e-05	0.000286	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GCLC—coronary artery disease	2.45e-05	0.000285	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCD—coronary artery disease	2.44e-05	0.000284	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR2A—coronary artery disease	2.39e-05	0.000278	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—C3—coronary artery disease	2.38e-05	0.000277	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HIF1A—coronary artery disease	2.27e-05	0.000265	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGT—coronary artery disease	2.26e-05	0.000264	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—coronary artery disease	2.25e-05	0.000262	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOE—coronary artery disease	2.22e-05	0.000258	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LEP—coronary artery disease	2.22e-05	0.000258	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOA1—coronary artery disease	2.19e-05	0.000255	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KDR—coronary artery disease	2.17e-05	0.000253	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK14—coronary artery disease	2.16e-05	0.000251	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ESR1—coronary artery disease	2.12e-05	0.000247	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	2.1e-05	0.000244	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FN1—coronary artery disease	2.09e-05	0.000244	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—F2—coronary artery disease	2.09e-05	0.000244	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6ST—coronary artery disease	2.08e-05	0.000243	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NFKBIA—coronary artery disease	2.07e-05	0.000241	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—coronary artery disease	2.01e-05	0.000234	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KIT—coronary artery disease	2e-05	0.000233	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GSK3B—coronary artery disease	1.92e-05	0.000224	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GGT1—coronary artery disease	1.91e-05	0.000222	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—POMC—coronary artery disease	1.91e-05	0.000222	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CREB1—coronary artery disease	1.91e-05	0.000222	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL2—coronary artery disease	1.86e-05	0.000217	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6R—coronary artery disease	1.86e-05	0.000216	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF1—coronary artery disease	1.83e-05	0.000213	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MAPK1—coronary artery disease	1.82e-05	0.000212	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.74e-05	0.000203	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SERPINE1—coronary artery disease	1.74e-05	0.000203	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CA5B—coronary artery disease	1.73e-05	0.000202	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	1.72e-05	0.0002	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	1.69e-05	0.000197	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGF2—coronary artery disease	1.68e-05	0.000196	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOS3—coronary artery disease	1.66e-05	0.000194	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—JAK2—coronary artery disease	1.61e-05	0.000188	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CA—coronary artery disease	1.58e-05	0.000184	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	1.58e-05	0.000184	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	1.55e-05	0.000181	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CKMT1B—coronary artery disease	1.47e-05	0.000172	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—coronary artery disease	1.47e-05	0.000172	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—coronary artery disease	1.42e-05	0.000166	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASP3—coronary artery disease	1.41e-05	0.000164	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—coronary artery disease	1.4e-05	0.000163	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCND1—coronary artery disease	1.37e-05	0.00016	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—coronary artery disease	1.33e-05	0.000155	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—coronary artery disease	1.29e-05	0.000151	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	1.2e-05	0.00014	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CKM—coronary artery disease	1.2e-05	0.00014	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPAP2B—coronary artery disease	1.2e-05	0.00014	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—coronary artery disease	1.2e-05	0.000139	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PDK4—coronary artery disease	1.12e-05	0.00013	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CKMT2—coronary artery disease	1.12e-05	0.00013	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	1.12e-05	0.00013	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SULT4A1—coronary artery disease	1.12e-05	0.00013	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PYGM—coronary artery disease	1.12e-05	0.00013	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—POMC—coronary artery disease	1.11e-05	0.00013	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFB1—coronary artery disease	1.1e-05	0.000128	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK1—coronary artery disease	1.08e-05	0.000125	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMGCS2—coronary artery disease	9.96e-06	0.000116	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GYG1—coronary artery disease	9.96e-06	0.000116	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GK—coronary artery disease	9.96e-06	0.000116	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LDHA—coronary artery disease	9.96e-06	0.000116	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PFKM—coronary artery disease	9.96e-06	0.000116	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GATM—coronary artery disease	9.96e-06	0.000116	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCH1—coronary artery disease	9.5e-06	0.000111	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AK1—coronary artery disease	9.5e-06	0.000111	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CA—coronary artery disease	9.35e-06	0.000109	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPAT—coronary artery disease	9.11e-06	0.000106	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCD1—coronary artery disease	9.11e-06	0.000106	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MDH2—coronary artery disease	9.11e-06	0.000106	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UGCG—coronary artery disease	9.11e-06	0.000106	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PGM1—coronary artery disease	8.77e-06	0.000102	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CKB—coronary artery disease	8.47e-06	9.87e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PYGB—coronary artery disease	8.47e-06	9.87e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—coronary artery disease	8.28e-06	9.64e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—COX5B—coronary artery disease	7.96e-06	9.28e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DLAT—coronary artery disease	7.96e-06	9.28e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLIN1—coronary artery disease	7.96e-06	9.28e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM2—coronary artery disease	7.96e-06	9.28e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PFKFB3—coronary artery disease	7.96e-06	9.28e-05	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—coronary artery disease	7.64e-06	8.9e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SULT1E1—coronary artery disease	7.55e-06	8.79e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKR1B1—coronary artery disease	7.2e-06	8.39e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HK2—coronary artery disease	7.2e-06	8.39e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC27A1—coronary artery disease	6.91e-06	8.04e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CPT1B—coronary artery disease	6.77e-06	7.89e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LCAT—coronary artery disease	6.77e-06	7.89e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA4—coronary artery disease	6.65e-06	7.74e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PDHA1—coronary artery disease	6.42e-06	7.48e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCLM—coronary artery disease	6.42e-06	7.48e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TXNRD1—coronary artery disease	6.22e-06	7.24e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP11B2—coronary artery disease	6.22e-06	7.24e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC22A3—coronary artery disease	6.12e-06	7.13e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ARNTL—coronary artery disease	6.04e-06	7.03e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HADH—coronary artery disease	6.04e-06	7.03e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.72e-06	6.66e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPX2—coronary artery disease	5.72e-06	6.66e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA2—coronary artery disease	5.72e-06	6.66e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.65e-06	6.58e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.65e-06	6.58e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HK1—coronary artery disease	5.65e-06	6.58e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPX4—coronary artery disease	5.65e-06	6.58e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HADHA—coronary artery disease	5.58e-06	6.5e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.52e-06	6.43e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPA—coronary artery disease	5.46e-06	6.36e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.29e-06	6.16e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA5—coronary artery disease	5.23e-06	6.09e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—P4HB—coronary artery disease	5.13e-06	5.98e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	5.04e-06	5.87e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—VCAN—coronary artery disease	4.75e-06	5.53e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.71e-06	5.49e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DCN—coronary artery disease	4.57e-06	5.33e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.45e-06	5.18e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LIPC—coronary artery disease	4.34e-06	5.05e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HBA1—coronary artery disease	4.34e-06	5.05e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.34e-06	5.05e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.34e-06	5.05e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOC3—coronary artery disease	4.31e-06	5.02e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LDLR—coronary artery disease	4.28e-06	4.99e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.23e-06	4.93e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.23e-06	4.93e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCLC—coronary artery disease	4.18e-06	4.87e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CETP—coronary artery disease	4.18e-06	4.87e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SDC1—coronary artery disease	4.14e-06	4.82e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.91e-06	4.55e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.91e-06	4.55e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CTGF—coronary artery disease	3.82e-06	4.45e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.78e-06	4.41e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT2—coronary artery disease	3.78e-06	4.41e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.48e-06	4.05e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.37e-06	3.93e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT1—coronary artery disease	3.27e-06	3.8e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GGT1—coronary artery disease	3.27e-06	3.8e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.93e-06	3.42e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.91e-06	3.39e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.89e-06	3.37e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAT—coronary artery disease	2.85e-06	3.32e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOB—coronary artery disease	2.77e-06	3.23e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.7e-06	3.14e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPL—coronary artery disease	2.65e-06	3.08e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPX1—coronary artery disease	2.58e-06	3.01e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CD36—coronary artery disease	2.51e-06	2.93e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.48e-06	2.89e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.38e-06	2.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AGT—coronary artery disease	2.26e-06	2.64e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOE—coronary artery disease	2.22e-06	2.58e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA1—coronary artery disease	2.19e-06	2.55e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARG—coronary artery disease	1.93e-06	2.25e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—POMC—coronary artery disease	1.91e-06	2.22e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—coronary artery disease	1.74e-06	2.02e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NOS3—coronary artery disease	1.66e-06	1.94e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.52e-06	1.77e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CA—coronary artery disease	9.35e-07	1.09e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—coronary artery disease	7.64e-07	8.9e-06	CbGpPWpGaD
